Remarkably, our rescue assay by overexpressing CREB in TMIGD2 knockdown cells largely restored the effects of TMIGD2 knockdown on cell self-renewal and differentiation, confirming that CREB was a bona fide functionally important target of TMIGD2 in AML. This evidence concerns the gene CREB1 and acute myeloid leukemia.